510(k) device
NeoTract UroLift System UL500
Neotract, Inc. · Implantable Transprostatic Tissue Retractor System (PEW, Class II) · First FDA decision Dec 20, 2013, newest Mar 15, 2016Enlarged prostate (BPH)
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
3
Naming "NeoTract UroLift"
MAUDE reports
300
Brand "NeoTract UroLift", since 2015
PubMed studies
0
Mentioning "NeoTract UroLift"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing NeoTract UroLift System UL500
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K153584 · Decided Mar 15, 2016 · 91 days after receipt
Device type: Implantable Transprostatic Tissue Retractor System (PEW) · GI, Urology & Nephrology
- NEOTRACT UROLIFT SYSTEM510(k)
K133281 · Decided Dec 20, 2013 · 56 days after receipt
Device type: Implantable Transprostatic Tissue Retractor System (PEW) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "NeoTract UroLift", any status and sponsor, newest update first.
NeoTract, Inc.Not on our public-company list
NCT01876706 · 51 participants · Start Apr 2013 · Primary completion Oct 2014
Device: UroLift® System · For: Benign Prostatic Hyperplasia
Sites: San Diego, California; Daytona Beach, Florida; St. Petersburg, Florida · 7 sites in all
- The Safety and Effectiveness of UroLift: LIFT Pivotal StudyPivotal-lookingCompleted
NeoTract, Inc.Not on our public-company list
NCT01294150 · 206 participants · Start Feb 2011 · Primary completion Feb 2013
Device: UroLift System; Crossover · For: Benign Prostatic Hyperplasia
Sites: San Diego, California; San Jose, California; Englewood, Colorado · 19 sites in all
NeoTract, Inc.Not on our public-company list
NCT01533038 · 80 participants · Start Feb 2012 · Primary completion Oct 2015
Device: UroLift System · For: Benign Prostatic Hyperplasia
Sites: Herlev, Denmark; Cologne, Germany; Freiburg im Breisgau, Germany · 9 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "NeoTract UroLift", and for the whole product code for context.
This brand
300 reports: 107 malfunction, 182 injury, 11 death
Whole product code PEW
498 reports: 250 malfunction, 236 injury, 12 death
Newest reports for this brand
- NEOTRACT UROLIFT SYSTEMMalfunction
HUDSON RESPIRATORY CARE TECATE
3015181082-2025-00048 · Received Apr 23, 2025 · Event dated Feb 10, 2025
Device type: Implantable Transprostatic Tissue Retractor System (PEW)
Device problem as coded: Fracture
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- NEOTRACT UROLIFT 2 SYSTEMMalfunction
3015181082-2025-00047 · Received Apr 3, 2025 · Event dated Jan 29, 2025
Device type: Implantable Transprostatic Tissue Retractor System (PEW)
Device problem as coded: Fracture
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- NEOTRACT UROLIFT SYSTEMInjury
HUDSON RESPIRATORY CARE TECATE
3015181082-2025-00046 · Received Apr 2, 2025 · Event dated Feb 3, 2025
Device type: Implantable Transprostatic Tissue Retractor System (PEW)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hematoma
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "NeoTract UroLift"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PEW.
- UroLift System (UL400)Neotract, Inc. · De Novo 2019
- UroLift 2 ATC Advanced Tissue Control SystemNeotract, Inc. · 510(k) 2023
- UroLift 2 System (formerly UL500)Neotract, Inc. · 510(k) 2020
- UroLift Advanced Tissue Control (ATC) SystemNeotract, Inc. · 510(k) 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.